
FDA Clears Initiation of COVID-19 Adaptive Platform Trial Developed by ACESO
Initiation of ACESO’s COVID-19 adaptive platform trial (PROTECT-APT) received FDA approval. FHI Clinical is the CRO and IND sponsor across sites internationally
Check out what we’ve been up to and where we can connect!
Initiation of ACESO’s COVID-19 adaptive platform trial (PROTECT-APT) received FDA approval. FHI Clinical is the CRO and IND sponsor across sites internationally
February 2, 2023
Oracle is supporting CROs with no-obligation access to its Clinical One platform through its CRO Growth Initiative. Read why we chose the platform as our default eClinical system.
January 30, 2023
Members of the PREVAIL team, with their research partners, recently published results from clinical trials of three vaccine regimens against Zaire Ebola virus disease (EVD).
December 21, 2022
FHI Clinical is contributing to the protocol design for a Phase 2 clinical trial to evaluate carboxyamidotriazole orotate (CTO), an asset from Tactical Therapeutics.
September 13-14, 2023
Attending BioPharm America? Schedule a meeting to chat with members of our team who will be available to talk about your ongoing and future projects
April 25-28, 2023
Dr. James Duworko, Director, PREVAIL, attended and presented about PREVAIL at the CelebrateLAB West Africa Conference 2023 in Abuja, Nigeria.
April 4, 2023
Join this roundtable, hosted by FHI Clinical, to discuss how we can use challenges and opportunities experienced during previous HIV vaccine development to inform future development efforts.
April 4-6, 2023
Attending World Vaccine Congress Washington 2023? Stop by our booth (#803) to chat with members of our team about our capabilities and services.
March 20-23, 2023
Attending Bio-Europe Spring? Schedule a meeting with an FHI Clinical team member who will be attending. We’d love to talk about future partnering opportunities!
March 16-17, 2023
Attending the 7th AMR Conference? Schedule a meeting with an FHI Clinical team member who will be attending to chat about how our experience with AMR can be used to support your upcoming trials.
FHI Clinical Headquarters
359 Blackwell Street, Suite 200
Durham, NC 27701 USA
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |